---
figid: PMC2879565__bcr2558-3
figlink: /pmc/articles/PMC2879565/figure/F3/
number: F3
caption: Therapeutic drugs that target various components of the phosphatidylinositol
  3-kinase (PI3K)/Akt pathway. EGFR, epidermal growth factor receptor; HER2, human
  epidermal growth factor receptor 2; mTOR, mammalian target of rapamycin; VEGFR,
  vascular endothelial growth factor receptor.
pmcid: PMC2879565
papertitle: 'Key signalling nodes in mammary gland development and cancer. Signalling
  downstream of PI3 kinase in mammary epithelium: a play in 3 Akts.'
reftext: Julie A Wickenden, et al. Breast Cancer Res. 2010;12(2):202-202.
pmc_ranked_result_index: '27790'
pathway_score: 0.6375897
filename: bcr2558-3.jpg
figtitle: Therapeutic drugs that target various components of the phosphatidylinositol
  3-kinase (PI3K)/Akt pathway
year: '2010'
organisms: Homo sapiens
ndex: 1ba8b2f8-df36-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2879565__bcr2558-3.html
  '@type': Dataset
  description: Therapeutic drugs that target various components of the phosphatidylinositol
    3-kinase (PI3K)/Akt pathway. EGFR, epidermal growth factor receptor; HER2, human
    epidermal growth factor receptor 2; mTOR, mammalian target of rapamycin; VEGFR,
    vascular endothelial growth factor receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - FLT1
  - PIK3CA
  - PIK3R3
  - AKT2
  - MTOR
  - EGFR
  - PIK3CB
  - AKT3
  - PIK3CD
  - FLT4
  - PIK3CG
  - KDR
  - PIK3R4
  - PIK3R6
  - PIK3R5
  - ERBB2
  - Perifosine
  - Canertinib
  - Vandetanib
  - Pazopanib
  - BEZ235
  - AZD8055
  - Rapamycin
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
chemicals:
- word: Perifosine
  source: MESH
  identifier: C105905
- word: Canertinib
  source: MESH
  identifier: C420268
- word: Vandetanib
  source: MESH
  identifier: C452423
- word: Pazopanib
  source: MESH
  identifier: C516667
- word: BEZ235
  source: MESH
  identifier: C531198
- word: AZD8055
  source: MESH
  identifier: C546624
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC2879565__F3
redirect_from: /figures/PMC2879565__F3
figtype: Figure
---
